Pyoderma gangrenosum: challenges and solutions

References

• FarhiDThe clinical and histopathological description of geometric phagedenism (pyoderma gangrenosum) by Louis Brocq one century agoArch Dermatol2008144675518559764
   PubMedGoogle Scholar
• GoldSPyoderma GangrenosumProc R Soc Med195649423423513322930
   PubMedGoogle Scholar
• MuendeIPyoderma GangrenosumProc R Soc Med196053429629714424997
   PubMedGoogle Scholar
• SuWPDavisMDWeenigRHPowellFCPerryHOPyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteriaInt J Dermatol2004431179080015533059
   PubMed Web of Science ®Google Scholar
• WollinaUPyoderma gangrenosum – a reviewOrphanet J Rare Dis200721917433111
   PubMed Web of Science ®Google Scholar
• WinesNWinesMRymanWUnderstanding pyoderma gangrenosum: a reviewMedGenMed200133611549979
   PubMedGoogle Scholar
• HempLHallSPyoderma gangrenosum: from misdiagnosis to recognition, a personal perspectiveJ Wound Care2009181252152620081578
   PubMedGoogle Scholar
• AlaviASajicDCerciFBGhazarianDRosenbachMJorizzoJNeutrophilic dermatoses: an updateAm J Clin Dermatol201415541342325154386
   PubMed Web of Science ®Google Scholar
• CardosoJCCoelhoSGonçaloMOliveiraHBritesMMFigueiredoAPioderma gangrenoso da parede abdominal após cesariana [Pyoderma gangrenosum of the abdominal wall after cesarean]Trab Soc Port Dermatol Venereol200866245250
   Google Scholar
• TanakaNFujiokaATajimaSIshibashiAHiroseSElafin is induced in epidermis in skin disorders with dermal neutrophilic infiltration: interleukin-1 beta and tumour necrosis factor-alpha stimulate its secretion in vitroBr J Dermatol2000143472873211069448
   PubMed Web of Science ®Google Scholar
• KlugerNUstekinumab for pyoderma gangrenosumArch Dermatol2012148565522782165
   PubMedGoogle Scholar
• KabashimaRSugitaKSawadaYHinoRNakamuraMTokuraYIncreased circulating Th17 frequencies and serum IL-22 levels in patients with acute generalized exanthematous pustulosisJ Eur Acad Dermatol Venereol201125448548820569282
   PubMed Web of Science ®Google Scholar
• MarzanoAVCugnoMTrevisanVRole of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseasesClin Exp Immunol2010162110010720636397
   PubMed Web of Science ®Google Scholar
• MarzanoAVFanoniDAntigaEExpression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet’s syndromeClin Exp Immunol20141781485624903614
   PubMed Web of Science ®Google Scholar
• KellerMSpanouZSchaerliPT Cell-regulated neutrophilic inflammation in autoinflammatory diseasesJ Immunol2005175117678768616301678
   PubMed Web of Science ®Google Scholar
• LowesMARussellCBMartinDATowneJEKruegerJGThe IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responsesTrends Immunol201334417418123291100
   PubMed Web of Science ®Google Scholar
• CaproniMAntigaEVolpiWThe Treg/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosumBrit J Dermatol Epub1202015
   Web of Science ®Google Scholar
• GuenovaETeskeAFehrenbacherBInterleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumabArch Dermatol2011147101203120521680759
   PubMedGoogle Scholar
• MarzanoAVCugnoMTrevisanVInflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatosesInt J Immunopathol Pharmacol201124245146021658319
   PubMed Web of Science ®Google Scholar
• DuchateletSMiskinyteSJoin-LambertOFirst Nicastrin mutation in PASH syndromeBr J Dermatol Epub1202015
   Web of Science ®Google Scholar
• DefilippisEMFeldmanSRHuangWWThe genetics of pyoderma gangrenosum and implications for treatment: a systematic reviewBr J Dermatol Epub10282014
   Web of Science ®Google Scholar
• BruzzeseVPyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapyJ Clin Rheumatol201218841341523188209
   PubMed Web of Science ®Google Scholar
• GoodarziHSivamaniRKGarciaMSEffective Strategies for the Management of Pyoderma GangrenosumAdv Wound Care (New Rochelle)20121519419924527305
   PubMedGoogle Scholar
• KowalzickLBertoliniJBaumannCWaltherBTruhmBEickenscheidtLParadoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritisJ Dtsch Dermatol Ges201311544744923343137
   PubMed Web of Science ®Google Scholar
• RuoccoESangiulianoSGravinaAGMirandaANicolettiGPyoderma gangrenosum: an updated reviewJ Eur Acad Dermatol Venereol20092391008101719470075
   PubMed Web of Science ®Google Scholar
• PereiraNBritesMMGonçaloMTellecheaOFigueiredoAPyoderma gangrenosum – a review of 24 cases observed over 10 yearsInt J Dermatol201352893894523676016
   PubMed Web of Science ®Google Scholar
• WuXRShenBDiagnosis and management of parastomal pyoderma gangrenosumGastroenterol Rep (Oxf)2013111824759661
   PubMedGoogle Scholar
• NguyenTVCowenEWLeslieKSAutoinflammation: From monogenic syndromes to common skin diseasesJ Am Acad Dermatol201368583485323453357
   PubMed Web of Science ®Google Scholar
• TüzünYMaraşoğluOPyoderma GangrenosumJ Turk acad Dermatol20071371301r
   Google Scholar
• ReichrathJBensGBonowitzATilgenWTreatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patientsJ Am Acad Dermatol200553227328316021123
   PubMed Web of Science ®Google Scholar
• LandisETTaheriAJorizzoJLGulliver’s sign: A recognizable transition from inflammatory to healing stages of pyoderma gangrenosumJ Dermatolog TreatIn press2014
   Web of Science ®Google Scholar
• Von den DrieschPPyoderma gangrenosum: a report of 44 cases with follow-upBr J Dermatol19971376100010059470924
   PubMed Web of Science ®Google Scholar
• PatelFFitzmauriceSDuongCEffective Strategies for the Management of Pyoderma Gangrenosum: A Comprehensive ReviewActa Derm VenereolIn press2014
   Web of Science ®Google Scholar
• OmiyaWUjiieHAkiyamaMCoexistence of pustular and vegetative pyoderma gangrenosum in a patient with myelodysplastic syndromeEur J Dermatol201222571171222858442
   PubMed Web of Science ®Google Scholar
• FelicianiCDe SimoneCAmerioPDermatological signs during inflammatory bowel diseasesEur Rev Med Pharmacol Sci200913Suppl 1152119530507
   PubMed Web of Science ®Google Scholar
• SpeeckaertRDe SmetLDe SchepperSPyoderma gangrenosum with granuloma formation: not always a benign disorderJ Eur Acad Dermatol Venereol Epub8292014
   Web of Science ®Google Scholar
• DasanuCABockornyBAlexandrescuDTPyoderma gangrenosum due to lenalidomide use for multiple myelomaJ Oncol Pharm PractIn press2014
   Web of Science ®Google Scholar
• DuchnowskaRZiajkaEGóralskaAGralaBRecurrent pyoderma gangrenosum precipitated by breast cancer: a case report and review of the literatureJ Med Case Rep2014822624965126
   PubMedGoogle Scholar
• DoriaAZenMBettioSAutoinflammation and autoimmunity: bridging the divideAutoimmun Rev2012121223022878274
   PubMed Web of Science ®Google Scholar
• CraigFFThomasKSMitchellEJUK Dermatology Clinical Trials Network’s STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trialTrials201228;1351
   Web of Science ®Google Scholar
• BrooklynTNDunnillMGShettyAInfliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trialGut200655450550916188920
   PubMed Web of Science ®Google Scholar
• SharonVBurrallBPatelFMultimodal therapy of idiopathic pyoderma gangrenosumDermatol Online J201415;206
   Google Scholar
• AndradePBritesMMFigueiredoASynchronous pyoderma gangrenosum and inflammatory bowel disease, healing after total proctocolectomyAn Bras Dermatol201287463763922892784
   PubMed Web of Science ®Google Scholar
• CosgareaILovricZKörberADissemondJSuccessful treatment of refractory pyoderma gangrenosum with ustekinumab only after excision of renal cell carcinomaInt Wound J Epub1082014
   Web of Science ®Google Scholar
• PazyarNFeilyAYaghoobiRAn overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseasesCurr Clin Pharmacol20127427127522794157
   PubMedGoogle Scholar
• NaikHBCowenEWAutoinflammatory pustular neutrophilic diseasesDermatol Clin201331340542523827244
   PubMed Web of Science ®Google Scholar
• YeMJYeJMPyoderma gangrenosum: a review of clinical features and outcomes of 23 cases requiring inpatient managementDermatol Res Pract Epub1082014
   Google Scholar
• DeMartynLEFallerNAMillerLTreating peristomal pyoderma gangrenosum with topical crushed prednisone: a report of three casesOstomy Wound Manage2014606505424905357
   PubMedGoogle Scholar
• KapilaSReidIDixitSUse of dermal injection of activated protein C for treatment of large chronic wounds secondary to pyoderma gangrenosumClin Exp Dermatol201439778579025155809
   PubMed Web of Science ®Google Scholar
• LiuDYFischerRFragaGAiresDJCollagenase ointment and topical timolol gel for treating idiopathic pyoderma gangrenosumJ Am Acad Dermatol2014715e225e22625438005
   PubMed Web of Science ®Google Scholar
• ImusGGolombCWilkelCTsoukasMNowakMFalangaVAccelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppressionJ Am Acad Dermatol2001441616611148478
   PubMed Web of Science ®Google Scholar
• SickITrautnerBRuzickaTSurgical management of Pyoderma gangrenosumHautarzt2012637577583 German22146897
   PubMed Web of Science ®Google Scholar
• CafardiJSamiNIntravenous immunoglobulin as salvage therapy in refractory pyoderma gangrenosum: report of a case and review of the literatureCase Rep Dermatol201423;63239244
   Google Scholar
• SinnyaSHamzaSPyoderma gangrenosum of the breast treated with intravenous immunoglobulinJ Dermatol Case Rep201330;72646824133564
   PubMedGoogle Scholar
• CampanatiABrisigottiVGanzettiGFinally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literatureJ Eur Acad Dermatol VenereolIn press2014
   Web of Science ®Google Scholar
• CinottiELabeilleBPerrotJLPallot-PradesBCambazardFCertolizumab for the treatment of refractory disseminated pyoderma gangrenosum associated with rheumatoid arthritisClin Exp Dermatol201439675075124984791
   PubMed Web of Science ®Google Scholar
• StaubJPfannschmidtNStrohalRSuccessful treatment of PASH syndrome with infliximab, cyclosporine and dapsoneJ Eur Acad Dermatol VenereolIn press2014
   Web of Science ®Google Scholar
• LanganSMGrovesRWCardTRGullifordMCIncidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort studyJ Invest Dermatol201213292166217022534879
   PubMed Web of Science ®Google Scholar
• BennettMLJacksonJMJorizzoJLFleischerABJrWhiteWLCallenJPPyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutionsMedicine (Baltimore)2000791374610670408
   PubMed Web of Science ®Google Scholar